Apex Biotechnology Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	162.89	128	115.78	181.79	202.22
Depreciation & Amortization	60.93	63.41	74.19	92.71	94.32
Other Amortization	-	1.4	1.52	1.39	1.35
Asset Writedown & Restructuring Costs	10.14	-	17.78	6	-
Loss (Gain) From Sale of Investments	-14.98	-4.23	3.96	29.48	-31.7
Stock-Based Compensation	-	-	-	-	1.59
Provision & Write-off of Bad Debts	14.32	0.05	1.82	-	-3.5
Other Operating Activities	-19.46	-11.24	10.85	-45.74	33.62
Change in Accounts Receivable	-88.39	-58.6	188.87	-1.38	-160.77
Change in Inventory	90.52	67.61	-17.96	-116.67	-136.05
Change in Accounts Payable	-4.34	67.96	-96.22	-59.51	99.31
Change in Unearned Revenue	-51.05	51.68	-22.45	-64.02	50.45
Change in Other Net Operating Assets	-0.47	22.64	-47.74	2.56	29.02
Operating Cash Flow	160.12	328.67	230.39	26.62	179.87
Operating Cash Flow Growth	-51.28%	42.66%	765.61%	-85.20%	-35.90%
Capital Expenditures	-15.26	-28.24	-21.91	-36.58	-26.59
Sale (Purchase) of Intangibles	-4	-1.39	-3.07	-4.07	-3.6
Investment in Securities	9.8	-	-	-0.7	-2
Other Investing Activities	3.92	-5.96	2.48	-0.01	-2.83
Investing Cash Flow	-5.54	-35.6	-22.5	-41.37	-35.02
Short-Term Debt Issued	18.27	29.45	281.16	964.61	1,690
Total Debt Issued	18.27	29.45	281.16	964.61	1,690
Short-Term Debt Repaid	-18.27	-59.45	-301.16	-1,065	-1,540
Long-Term Debt Repaid	-8.72	-8.7	-8.2	-7.68	-404.2
Total Debt Repaid	-26.98	-68.15	-309.35	-1,072	-1,944
Net Debt Issued (Repaid)	-8.72	-38.7	-28.2	-107.68	-254.2
Issuance of Common Stock	-	-	-	-	12.25
Common Dividends Paid	-119.94	-109.95	-139.93	-129.94	-109.32
Other Financing Activities	-	-0.03	-0.02	0.01	-0.01
Financing Cash Flow	-128.66	-148.67	-168.14	-237.6	-351.27
Foreign Exchange Rate Adjustments	8.49	6.24	10.59	28.72	-25.19
Net Cash Flow	34.41	150.64	50.34	-223.63	-231.61
Free Cash Flow	144.86	300.43	208.48	-9.97	153.28
Free Cash Flow Growth	-51.78%	44.10%	-	-	-34.87%
Free Cash Flow Margin	7.45%	16.22%	12.44%	-0.44%	7.19%
Free Cash Flow Per Share	1.44	2.99	2.08	-0.10	1.45
Cash Interest Paid	3.39	3.64	4.39	5.4	4.7
Cash Income Tax Paid	21.77	48.43	18.9	24.04	9.19
Levered Free Cash Flow	98.15	254.23	164.39	-78.18	55.06
Unlevered Free Cash Flow	100.27	256.51	167.14	-74.81	62.89
Change in Working Capital	-53.73	151.29	4.5	-239.01	-118.04

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.